An obesity drug rejected for use by the Scottish NHS will be available on prescription in England and Wales.
Early trials have shown the treatment rimonabant, which suppresses appetite, could help patients lose up to 10% of their body weight.
An obesity drug rejected for use by the Scottish NHS will be available on prescription in England and Wales.
An obesity drug rejected for use by the Scottish NHS will be available on prescription in England and Wales.
Early trials have shown the treatment rimonabant, which suppresses appetite, could help patients lose up to 10% of their body weight.